Oncology

Scientists override tumor growth effects of PTEN deletion.

Upcoming trial of Opdivo harnesses the immune system to target mesothelioma.

Prostate cancer care costs in the United states is more than $10 billion per year.

Latest efforts help scientists identify the efficacy of immune treatments in patients with cancer.

Reducing overall body fat associated with lower levels of breast cancer markers.

New blood test more precisely distinguishes cancer from benign conditions, and identifies patients at high-risk of disease.

No evidence found that erectile dysfunction drugs cause melanoma.

Tumor biology may differ when cancer recurs.

Top news of the day from across the health care landscape.

Nanoparticle vaccines can travel directly to the lymph nodes to activate tumor-specific immune responses.

Imatinib found to reduce measures of airway inflammation in severe asthma.

Top articles of the week from The American Journal of Pharmacy Benefits.

Top news of the week in oncology and cancer drug development.

A novel AI image detection method could potentially outperform current PAP and HPV tests.

Top news of the day from across the health care landscape.

The Guide to Hepatitis C Testing addresses widespread uncertainty regarding HCV treatment.

The Guide to Hepatitis C Testing summarizes the latest examination recommendations.

Keytruda demonstrated statistically significant improvements in overall survival.

Pembrolizumab shows statistically significant improvements in overall survival and objective response rate in cancer treatment.

Southern Italy tomato varieties demonstrated a potential role against typical neoplastic features.

Nanoparticle precisely delivers tumor antigens to immune cells while stimulating immunity.

Breast cancer incidence has climbed among Asian Americans, while diagnosis rates among other groups have trended downward.

Substantial increase in breast cancer incidences among Koreans, South Asians, and Southeast Asians.

Tracking unstable chromosomes allows scientists to peer into the evolution of NSCLC.

Keytruda found to improve the overall response rate in pediatric and adult patients with cHL.

Pembrolizumab approved for adults and pediatric patients with refractory classical Hodgkin lymphoma.

Study examines how bacteria in the digestive tract might increase or decrease response to cancer drugs.

Chronic hepatitis B virus is still a problem in many parts of the world and the United States, despite the availability of a vaccine.